New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2012
07:12 EDTVICLVical coverage assumed with an Outperform at Credit Suisse
Target $5.
News For VICL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2015
09:19 EDTVICLOn The Fly: Pre-market Movers
Subscribe for More Information
06:32 EDTVICLVicall's antifungal product candidate granted QIDP designation by FDA
Vical announced that the FDA has granted a qualified infectious disease product, or QIDP, designation to Vical's investigational antifungal product candidate, VL-2397. The QIDP designation is for the treatment of invasive aspergillosis. The QIDP designation provides certain incentives for the development of new anti-infectives, including eligibility for priority review, the FDA's Fast Track program, and a five-year extension of exclusivity.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use